COMMUNIQUÉS West-GlobeNewswire

Grant of Warrants
20/12/2018
December 20, 2018 Announcement no. 26 Grant of Warrants In accordance with the company's guidelines relating to incentive remuneration and the authorization in Section 18 of the Articles of Association, the Board of [...]
Novartis announces new CEO of Oncology Business Unit
20/12/2018
Susanne Schaffert, Ph.D., President, AAA, an established Novartis executive, named new CEO, Novartis Oncology Basel, December 20, 2018 - Novartis announced today that Susanne Schaffert, Ph.D., currently President, [...]
MannKind Announces Pricing of $40 Million Public Offering
20/12/2018
WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced the pricing of an underwritten public offering of 26,666,667 shares of its common stock and [...]
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions
19/12/2018
FDA Issues Complete Response Letter for PAS Drug Substance, Approves PAS for Drug Product RAMSEY, N.J. and BOCA RATON, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company [...]
GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference
19/12/2018
CARLSBAD, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the Company plans to [...]
DBV Technologies: DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age
19/12/2018
Montrouge, France, December 19, 2018 DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age BLA withdrawn following discussions with FDA regarding insufficient data on manufacturing [...]
DBV Technologies : Nouvelles informations concernant Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans
19/12/2018
Montrouge, France, 19 Décembre (23 :00 CET), 2018 Nouvelles informations concernant Viaskin Peanut pour le traitement des enfants âgés de 4 à 11 ans DBV a décidé de retirer son dossier de demande d'enregistrement (BLA) [...]
Inspire Medical Systems, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference
19/12/2018
MINNEAPOLIS, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)
19/12/2018
Company Release no. 22/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 19 December 2018 FDA Approves New Indication for ENVARSUS XR ® (tacrolimus extended-release tablets) Veloxis Pharmaceuticals announced today [...]
Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
19/12/2018
ALPHARETTA, Ga., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Soleno Therapeutics Announces $16.5 Million Private Placement
19/12/2018
Financing Led by Abingworth; Andrew Sinclair, Partner, to Join Soleno’s Board Funding to Support Ongoing Phase III Clinical Program (DESTINY PWS) for DCCR in Prader-Willi Syndrome REDWOOD CITY, Calif., Dec. 19, 2018 ( [...]
MannKind Announces Commencement of Public Offering
19/12/2018
WESTLAKE VILLAGE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) (MannKind) today announced that it has commenced an underwritten public offering to issue and sell shares of its common [...]
G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib Showing Multi-Lineage Myelopreservation Benefits in 2nd-/3rd-Line Small Cell Lung Cancer
19/12/2018
Achieved both primary endpoints: statistically significant reductions in the duration and occurrence of Grade 4 neutropenia Clinically meaningful reductions in rates of granulocyte-colony stimulating factor (G-CSF) [...]
Amicus Therapeutics Announces Executive Team Updates
19/12/2018
Daphne Quimi Promoted to Chief Financial Officer David Clark Joins as Chief People Officer Ellen Rosenberg Promoted to Chief Legal Officer CRANBURY, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: [...]
AgraFlora Organics 2.2 Million Square Foot Delta Facility is the Second Largest Cannabis Greenhouse in Canada
19/12/2018
VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Agraflora Organics International Inc. (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF) (formerly PUF Ventures Inc.) released a three stage timeline last week [...]
NeuroMetrix to Present at Upcoming Biotech Showcase 2019 In San Francisco
19/12/2018
WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2019 [...]
BRACAnalysis CDx® Approved by U.S. Food and Drug Administration as Companion Diagnostic for AstraZeneca’s Lynparza® (olaparib) in Patients with Advanced-Stage, BRCA-Mutated Ovarian Cancer
19/12/2018
SALT LAKE CITY, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration (FDA) has [...]
AB Science provides an update on the restructuring of its clinical development department in 2018
19/12/2018
Paris, December 19, 2018, 6pm Update on restructuring of the AB Science clinical development department in 2018 AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specialized in the research and [...]
AB Science fait le point sur sa réorganisation du développement clinique en 2018
19/12/2018
Paris, 19 décembre 2018, 18h Point sur la réorganisation du développement clinique d'AB Science en 2018 AB Science SA (NYSE Euronext - FR0010557264 - AB), société pharmaceutique spécialisée dans la recherche et le [...]

Pages